Long-term cardiovascular consequences of fetal growth restriction: biology, clinical implications, and opportunities for prevention of adult disease

American Journal of Obstetrics and Gynecology

Volumn 218, Issue 2, 2018, Pages S869-S879

  Crispi, Fatima ^a   Miranda, Jezid ^a   Gratacós, Eduard ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

cardiovascular disease; echocardiography; epigenetics; fetal growth restriction and fetal programming

Indexed keywords

ADOLESCENCE; ADULT DISEASE; ADULTHOOD; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CHILDHOOD; CLINICAL FEATURE; DISEASE SEVERITY; ENDOTHELIUM; HEART DISEASE; HUMAN; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL; REVIEW; VASCULAR REMODELING; ADAPTATION; ADULT; FEMALE; FETUS DEVELOPMENT; GENETIC EPIGENESIS; GENETICS; HEART ATRIUM REMODELING; HEART VENTRICLE REMODELING; MALE; PREGNANCY; PRENATAL EXPOSURE;

ADAPTATION, PHYSIOLOGICAL; ADULT; ATRIAL REMODELING; CARDIOVASCULAR DISEASES; EPIGENESIS, GENETIC; FEMALE; FETAL DEVELOPMENT; FETAL GROWTH RETARDATION; HUMANS; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; VASCULAR REMODELING; VENTRICULAR REMODELING;

EID: 85044612450     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2017.12.012     Document Type: Review

References (157)

1. Gluckman, P.D., Hanson, M.A., Living with the past: evolution, development, and patterns of disease. Science 305 (2004), 1733–1736.
2. Li, S., Chen, W., Srinivasan, S.R., et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA 290 (2003), 2271–2276.
3. Leistikow, E.A., Is coronary artery disease initiated perinatally?. Semin Thromb Hemost 24 (1998), 139–143.
4. Barker, D.J.P., Osmond, C., Winter, P.D., Margetts, B., Simmonds, S.J., Weight in infancy and death from ischaemic heart disease. Lancet 334 (1989), 577–580.
5. Rich-Edwards, J.W., Stampfer, M.J., Manson, J.E., et al. Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. BMJ 315 (1997), 396–400.
6. Leon, D.A., Lithell, H.O., Vâgerö, D., et al. Reduced fetal growth rate and increased risk of death from ischaemic heart disease: cohort study of 15 000 Swedish men and women born 1915-29. BMJ 317 (1998), 241–245.
7. Syddall, H.E., Aihie Sayer, A., Simmonds, S.J., et al. Birth weight, infant weight gain, and cause-specific mortality: the Hertfordshire Cohort study. Am J Epidemiol 161 (2005), 1074–1080.
8. Lawlor, D.A., Davey Smith, G., Ebrahim, S., Birth weight is inversely associated with coronary heart disease in post-menopausal women: findings from the British women's heart and health study. J Epidemiol Community Health 58 (2004), 120–125.
9. Frankel, S., Elwood, P., Sweetnam, P., Yarnell, J., Davey Smith, G., Birthweight, adult risk factors and incident coronary heart disease: the Caerphilly study. Public Health 110 (1996), 139–143.
10. Lawlor, D.A., Ronalds, G., Clark, H., Smith, G.D., Leon, D.A., Birth weight is inversely associated with incident coronary heart disease and stroke among individuals born in the 1950s: findings from the Aberdeen Children of the 1950s prospective cohort study. Circulation 112 (2005), 1414–1418.
11. Osmond, C., Barker, D.J., Winter, P.D., Fall, C.H., Simmonds, S.J., Early growth and death from cardiovascular disease in women. BMJ 307 (1993), 1519–1524.
12. Eriksson, J.G., Forsén, T., Tuomilehto, J., Osmond, C., Barker, D.J., Early growth and coronary heart disease in later life: longitudinal study. BMJ 322 (2001), 949–953.
13. Law, C.M., Shiell, A.W., Is blood pressure inversely related to birth weight? The strength of evidence from a systematic review of the literature. J Hypertens 14 (1996), 935–941.
14. Leon, D.A., Koupilova, I., Lithell, H.O., et al. Failure to realise growth potential in utero and adult obesity in relation to blood pressure in 50 year old Swedish men. BMJ 312 (1996), 401–406.
15. Barker, D.J., Hales, C.N., Fall, C.H., et al. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36 (1993), 62–67.
16. Huxley, R.R., Shiell, A.W., Law, C.M., The role of size at birth and postnatal catch-up growth in determining systolic blood pressure: a systematic review of the literature. J Hypertens 18 (2000), 815–831.
17. Hales, C.N., Barker, D.J., Clark, P.M., et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 303 (1991), 1019–1022.
18. Lithell, H.O., McKeigue, P.M., Berglund, L., et al. Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years. BMJ 312 (1996), 406–410.
19. Stein, C.E., Fall, C.H., Kumaran, K., et al. Fetal growth and coronary heart disease in south India. Lancet 348 (1996), 1269–1273.
20. Barker, D.J., Fetal origins of cardiovascular disease. Ann Med 31:suppl1 (1999), 3–6.
21. Barker, D., The fetal and infant origins of adult disease. BMJ, 301, 1990, 1111.
22. Barker, D.J.P., The origins of the developmental origins theory. J Intern Med 261 (2007), 412–417.
23. Neel, J.V., Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”?. Am J Hum Genet 14 (1962), 353–362.
24. Godfrey, K.M., Gluckman, P.D., Hanson, M.A., Developmental origins of metabolic disease: life course and intergenerational perspectives. Trends Endocrinol Metab 21 (2010), 199–205.
25. Hales, C.N., Barker, D.J., Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35 (1992), 595–601.
26. Gluckman, P.D., Hanson, M.A., Spencer, H.G., Bateson, P., Environmental influences during development and their later consequences for health and disease: implications for the interpretation of empirical studies. Proc Biol Sci 272 (2005), 671–677.
27. Gluckman, P.D., Hanson, M.A., Cooper, C., Thornburg, K.L., Effect of in utero and early-life conditions and adult health and disease. N Engl J Med 359 (2008), 61–73.
28. Bateson, P., Barker, D., Clutton-Brock, T., et al. Developmental plasticity and human health. Nature 430 (2004), 419–421.
29. Lillycrop, K.A., Phillips, E.S., Jackson, A.A., Hanson, M.A., Burdge, G.C., Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J Nutr 135 (2005), 1382–1386.
30. Lillycrop, K.A., Slater-Jefferies, J.L., Hanson, M.A., et al. Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications. Br J Nutr 97 (2007), 1064–1073.
31. Wells, J.C.K., Maternal capital and the metabolic ghetto: an evolutionary perspective on the transgenerational basis of health inequalities. Am J Hum Biol 22 (2010), 1–17.
32. Barker, D.J.P., Osmond, C., Forsén, T.J., Kajantie, E., Eriksson, J.G., Trajectories of growth among children who have coronary events as adults. N Engl J Med 353 (2005), 1802–1809.
33. Eriksson, J.G., Osmond, C., Kajantie, E., Forsén, T.J., Barker, D.J.P., Patterns of growth among children who later develop type 2 diabetes or its risk factors. Diabetologia 49 (2006), 2853–2858.
34. Parsons, T.J., Power, C., Manor, O., Fetal and early life growth and body mass index from birth to early adulthood in 1958 British cohort: longitudinal study. BMJ 323 (2001), 1331–1335.
35. Harville, E.W., Srinivasan, S., Chen, W., Berenson, G.S., Is the Metabolic syndrome a “small baby” syndrome? The Bogalusa Heart Study. Metab Syndr Relat Disord 10 (2012), 413–421.
36. Kuzawa, C.W., Fetal origins of developmental plasticity: Are fetal cues reliable predictors of future nutritional environments?. Am J Hum Biol 17 (2005), 5–21.
37. Gregorio, B.M., Souza-Mello, V., Mandarim-de-Lacerda, C.A., Aguila, M.B., Maternal fish oil supplementation benefits programmed offspring from rat dams fed low-protein diet. Am J Obstet Gynecol 199 (2008), 82.e1–82.e7.
38. Sehgal, A., Skilton, M.R., Crispi, F., Human fetal growth restriction: a cardiovascular journey through to adolescence. J Dev Orig Health Dis 7 (2016), 626–635.
39. Lee, A.C.C., Katz, J., Blencowe, H., et al. National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010. Lancet Glob Heal 1 (2013), e26–e36.
40. Oros, D., Figueras, F., Cruz-Martinez, R., et al. Longitudinal changes in uterine, umbilical and fetal cerebral Doppler indices in late-onset small-for-gestational age fetuses. Ultrasound Obstet Gynecol 37 (2011), 191–195.
41. Hecher, K., Bilardo, C.M., Stigter, R.H., et al. Monitoring of fetuses with intrauterine growth restriction: a longitudinal study. Ultrasound Obstet Gynecol 18 (2001), 564–570.
42. Turan, O.M., Turan, S., Gungor, S., et al. Progression of Doppler abnormalities in intrauterine growth restriction. Ultrasound Obstet Gynecol 32 (2008), 160–167.
43. Savchev, S., Figueras, F., Sanz-Cortes, M., et al. Evaluation of an optimal gestational age cut-off for the definition of early-and late-onset fetal growth restriction. Fetal Diagn Ther 36 (2014), 99–105.
44. Figueras, F., Gratacos, E., Stage-based approach to the management of fetal growth restriction. Prenat Diagn 34 (2014), 655–659.
45. Figueras, F., Gratacos, E., An integrated approach to fetal growth restriction. Best Pract Res Clin Obstet Gynaecol 38 (2017), 48–58.
46. Figueras, F., Gratacós, E., Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol. Fetal Diagn Ther 36 (2014), 86–98.
47. DeVore, G.R., The importance of the cerebroplacental ratio in the evaluation of fetal well-being in SGA and AGA fetuses. Am J Obstet Gynecol 213 (2015), 5–15.
48. Crovetto, F., Crispi, F., Scazzocchio, E., et al. First-trimester screening for early and late small-for-gestational-age neonates using maternal serum biochemistry, blood pressure and uterine artery Doppler. Ultrasound Obstet Gynecol 43 (2014), 34–40.
49. Baschat, A.A., Cosmi, E., Bilardo, C.M., et al. Predictors of neonatal outcome in early-onset placental dysfunction. Obstet Gynecol 109 (2007), 253–261.
50. Lees, C., Marlow, N., Arabin, B., et al. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol 42 (2013), 400–408.
51. Mendez-Figueroa, H., Truong, V.T.T., Pedroza, C., Khan, A.M., Chauhan, S.P., Small-for-gestational-age infants among uncomplicated pregnancies at term: a secondary analysis of 9 Maternal-Fetal Medicine Units Network studies. Am J Obstet Gynecol 215 (2016), 628.e1–628.e7.
52. Zhu, M.Y., Milligan, N., Keating, S., et al. The hemodynamics of late-onset intrauterine growth restriction by MRI. Am J Obstet Gynecol 214 (2016), 367.e1–367.e17.
53. Chang, T.C., Robson, S.C., Spencer, J.A.D., Gallivan, S., Prediction of perinatal morbidity at term in small fetuses: comparison of fetal growth and Doppler ultrasound. BJOG 101 (1994), 422–427.
54. Cruz-Lemini, M., Crispi, F., Van Mieghem, T., et al. Risk of perinatal death in early-onset intrauterine growth restriction according to gestational age and cardiovascular Doppler indices: a multicenter study. Fetal Diagn Ther 32 (2012), 116–122.
55. Figueras, F., Puerto, B., Martinez, J.M., Cararach, V., Vanrell, J.A., Cardiac function monitoring of fetuses with growth restriction. Eur J Obstet Gynecol Reprod Biol 110 (2003), 159–163.
56. Crispi, F., Bijnens, B., Figueras, F., et al. Fetal growth restriction results in remodeled and less efficient hearts in children. Circulation 121 (2010), 2427–2436.
57. Crispi, F., Figueras, F., Cruz-Lemini, M., et al. Cardiovascular programming in children born small for gestational age and relationship with prenatal signs of severity. Am J Obstet Gynecol 207 (2012), 121.e1–121.e9.
58. Cruz-Lemini, M., Crispi, F., Valenzuela-Alcaraz, B., et al. A fetal cardiovascular score to predict infant hypertension and arterial remodeling in intrauterine growth restriction. Am J Obstet Gynecol 210 (2014), 552.e1–552.e22.
59. Tsyvian, P., Malkin, K., Wladimiroff, J.W., Assessment of fetal left cardiac isovolumic relaxation time in appropriate and small-for-gestational-age fetuses. Ultrasound Med Biol 21 (1995), 739–743.
60. Rodríguez-López, M., Cruz-Lemini, M., Valenzuela-Alcaraz, B., et al. Descriptive analysis of the different phenotypes of cardiac remodeling in fetal growth restriction. Ultrasound Obstet Gynecol 109 (2016), 2079–2088.
61. Crispi, F., Gratacos, E., Fetal cardiac function: technical considerations and potential research and clinical applications. Fetal Diagn Ther 32 (2012), 47–64.
62. Hernandez-Andrade, E., Benavides-Serralde, J.A., Cruz-Martinez, R., Welsh, A., Mancilla-Ramirez, J., Evaluation of conventional Doppler fetal cardiac function parameters: E/A ratios, outflow tracts, and myocardial performance index. Fetal Diagn Ther 32 (2012), 22–29.
63. Comas, M., Crispi, F., Cruz-Martinez, R., Figueras, F., Gratacos, E., Tissue Doppler echocardiographic markers of cardiac dysfunction in small-for-gestational age fetuses. Am J Obstet Gynecol 205 (2011), 57.e1–57.e6.
64. Naujorks, A.A., Zielinsky, P., Beltrame, P.A., et al. Myocardial tissue Doppler assessment of diastolic function in the growth-restricted fetus. Ultrasound Obstet Gynecol 34 (2009), 68–73.
65. Cruz-Lemini, M., Crispi, F., Valenzuela-Alcaraz, B., et al. Value of annular M-mode displacement vs tissue Doppler velocities to assess cardiac function in intrauterine growth restriction. Ultrasound Obstet Gynecol 42 (2013), 175–181.
66. Crispi, F., Hernandez-Andrade, E., Pelsers, M.M.A.L., et al. Cardiac dysfunction and cell damage across clinical stages of severity in growth-restricted fetuses. Am J Obstet Gynecol 199 (2008), 254.e1–254.e8.
67. Gardiner, H., Brodszki, J., Marl, K., Ventriculovascular physiology of the growth-restricted fetus. Ultrasound Obstet Gynecol 18 (2001), 47–53.
68. Bilardo, C.M., Wolf, H., Stigter, R.H., et al. Relationship between monitoring parameters and perinatal outcome in severe, early intrauterine growth restriction. Ultrasound Obstet Gynecol 23 (2004), 119–125.
69. Mäkikallio, K., Vuolteenaho, O., Jouppila, P., Räsänen, J., Ultrasonographic and biochemical markers of human fetal cardiac dysfunction in placental insufficiency. Circulation 105 (2002), 2058–2063.
70. Larsen, L.U., Petersen, O.B., Sloth, E., Uldbjerg, N., Color Doppler myocardial imaging demonstrates reduced diastolic tissue velocity in growth retarded fetuses with flow redistribution. Eur J Obstet Gynecol Reprod Biol 155 (2011), 140–145.
71. Girsen, A., Ala-Kopsala, M., Mäkikallio, K., Vuolteenaho, O., Räsänen, J., Cardiovascular hemodynamics and umbilical artery N-terminal peptide of proB-type natriuretic peptide in human fetuses with growth restriction. Ultrasound Obstet Gynecol 29 (2007), 296–303.
72. Bozynski, M.E., Hanafy, F.H., Hernandez, R.J., Association of increased cardiothoracic ratio and intrauterine growth retardation. Am J Perinatol 8 (1991), 28–30.
73. Kiserud, T., Ebbing, C., Kessler, J., Rasmussen, S., Fetal cardiac output, distribution to the placenta and impact of placental compromise. Ultrasound Obstet Gynecol 28 (2006), 126–136.
74. Crispi, F., Bijnens, B., Sepulveda-Swatson, E., et al. Postsystolic shortening by myocardial deformation imaging as a sign of cardiac adaptation to pressure overload in fetal growth restriction. Circ Cardiovasc Imaging 7 (2014), 781–787.
75. Chaiworapongsa, T., Espinoza, J., Yoshimatsu, J., et al. Subclinical myocardial injury in small-for-gestational-age neonates. J Matern Fetal Neonatal Med 11 (2002), 385–390.
76. Sehgal, A., Doctor, T., Menahem, S., Cardiac function and arterial indices in infants born small for gestational age: analysis by speckle tracking. Acta Paediatr 103 (2014), e49–e54.
77. Altin, H., Karaarslan, S., Karataş, Z., et al. Evaluation of cardiac functions in term small for gestational age newborns with mild growth retardation: a serial conventional and tissue Doppler imaging echocardiographic study. Early Hum Dev 88 (2012), 757–764.
78. Fouzas, S., Karatza, A.A., Davlouros, P.A., et al. Neonatal cardiac dysfunction in intrauterine growth restriction. Pediatr Res 75 (2014), 651–657.
79. Sehgal, A., Doctor, T., Menahem, S., Cardiac function and arterial biophysical properties in small for gestational age infants: postnatal manifestations of fetal programming. J Pediatr 163 (2013), 1296–1300.
80. Skilton, M.R., Evans, N., Griffiths, K.A., Harmer, J.A., Celermajer, D.S., Aortic wall thickness in newborns with intrauterine growth restriction. Lancet 365 (2005), 1484–1486.
81. Tauzin, L., Rossi, P., Giusano, B., et al. Characteristics of arterial stiffness in very low birth weight premature infants. Pediatr Res 60 (2006), 592–596.
82. Zanardo, V., Fanelli, T., Weiner, G., et al. Intrauterine growth restriction is associated with persistent aortic wall thickening and glomerular proteinuria during infancy. Kidney Int 80 (2011), 119–123.
83. Litwin, M., Niemirska, A., Intima-media thickness measurements in children with cardiovascular risk factors. Pediatr Nephrol 24 (2009), 707–719.
84. Martin, H., Hu, J., Gennser, G., Norman, M., Impaired endothelial function and increased carotid stiffness in 9-year-old children with low birthweight. Circulation 102 (2000), 2739–2744.
85. Napoli, C., Glass, C.K., Witztum, J.L., et al. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet 354 (1999), 1234–1241.
86. Sarvari, S.I., Rodriguez-Lopez, M., Nuñez-Garcia, M., et al. Persistence of cardiac remodeling in preadolescents with fetal growth restriction. Circ Cardiovasc Imaging, 10, 2017, 10.1161/CIRCIMAGING.116.005270.
87. Brodszki, J., Länne, T., Maršál, K., Ley, D., Impaired vascular growth in late adolescence after intrauterine growth restriction. Circulation 111 (2005), 2623–2628.
88. Bjarnegård, N., Morsing, E., Cinthio, M., Länne, T., Brodszki, J., Cardiovascular function in adulthood following intrauterine growth restriction with abnormal fetal blood flow. Ultrasound Obstet Gynecol 41 (2013), 177–184.
89. Dratva, J., Breton, C.V., Hodis, H.N., et al. Birth weight and carotid artery intima-media thickness. J Pediatr 162:906 (2013), 11–12.
90. Skilton, M.R., Pahkala, K., Viikari, J.S.A., et al. The association of dietary alpha-linolenic acid with blood pressure and subclinical atherosclerosis in people born small for gestational age: the Special Turku Coronary Risk Factor Intervention Project study. J Pediatr 166 (2015), 1252–1257.e2.
91. Nilsson, P.M., Ostergren, P.O., Nyberg, P., Söderström, M., Allebeck, P., Low birth weight is associated with elevated systolic blood pressure in adolescence: a prospective study of a birth cohort of 149378 Swedish boys. J Hypertens 15 (1997), 1627–1631.
92. Raitakari, O.T., Juonala, M., Rönnemaa, T., et al. Cohort profile: the cardiovascular risk in young Finns study. Int J Epidemiol 37 (2008), 1220–1226.
93. Skilton, M.R., Viikari, J.S.A., Juonala, M., et al. Fetal growth and preterm birth influence cardiovascular risk factors and arterial health in young adults: The cardiovascular risk in young finns study. Arterioscler Thromb Vasc Biol 31 (2011), 2975–2981.
94. Arnott, C., Skilton, M.R., Ruohonen, S., et al. Subtle increases in heart size persist into adulthood in growth restricted babies: the Cardiovascular Risk in Young Finns Study. Open Heart, 2, 2015, e000265.
95. Miles, K.L., McDonnell, B.J., Maki-Petaja, K.M., et al. The impact of birth weight on blood pressure and arterial stiffness in later life: the Enigma Study. J Hypertens 29 (2011), 2324–2331.
96. Hack, M., Schluchter, M., Cartar, L., Rahman, M., Blood pressure among very low birth weight (<1.5 kg) young adults. Pediatr Res 58 (2005), 677–684.
97. Lewandowski, A.J., Augustine, D., Lamata, P., et al. Preterm heart in adult life: Cardiovascular magnetic resonance reveals distinct differences in left ventricular mass, geometry, and function. Circulation 127 (2013), 197–206.
98. De Jong, F., Monuteaux, M.C., Van Elburg, R.M., Gillman, M.W., Belfort, M.B., Systematic review and meta-analysis of preterm birth and later systolic blood pressure. Hypertension 59 (2012), 226–234.
99. Finken, M.J.J., Keijzer-Veen, M.G., Dekker, F.W., et al. Preterm birth and later insulin resistance: effects of birth weight and postnatal growth in a population based longitudinal study from birth into adult life. Diabetologia 49 (2006), 478–485.
100. Wang, G., Divall, S., Radovick, S., et al. Preterm birth and random plasma insulin levels at birth and in early childhood. JAMA, 311, 2014, 587.
101. Carr, H., Cnattingius, S., Granath, F., Ludvigsson, J.F., Edstedt Bonamy, A.K., Preterm birth and risk of heart failure up to early adulthood. J Am Coll Cardiol 69 (2017), 2634–2642.
102. Sehgal, A., Allison, B.J., Gwini, S.M., et al. Vascular aging and cardiac maladaptation in growth-restricted preterm infants. J Perinatol, 2017 Epub ahead of print.
103. Ferreira, I., Peeters, L.L., Stehouwer, C.D.A., Preeclampsia and increased blood pressure in the offspring: meta-analysis and critical review of the evidence. J Hypertens 27 (2009), 1955–1959.
104. Geelhoed, J.J.M., Fraser, A., Tilling, K., et al. Preeclampsia and gestational hypertension are associated with childhood blood pressure independently of family adiposity measures: the Avon longitudinal study of parents and children. Circulation 122 (2010), 1192–1199.
105. Kajantie, E., Eriksson, J.G., Osmond, C., Thornburg, K., Barker, D.J.P., Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke 40 (2009), 1176–1180.
106. Lazdam, M., De La Horra, A., Pitcher, A., et al. Elevated blood pressure in offspring born premature to hypertensive pregnancy: is endothelial dysfunction the underlying vascular mechanism?. Hypertension 56 (2010), 159–165.
107. Roberts, V.H.J., Frias, A.E., Grove, K.L., Impact of maternal obesity on fetal programming of cardiovascular disease. Physiology (Bethesda) 30 (2015), 224–231.
108. Manderson, J.G., Mullan, B., Patterson, C.C., et al. Cardiovascular and metabolic abnormalities in the offspring of diabetic pregnancy. Diabetologia 45 (2002), 991–996.
109. Stuart, A., Amer-Wåhlin, I., Persson, J., Källen, K., Long-term cardiovascular risk in relation to birth weight and exposure to maternal diabetes mellitus. Int J Cardiol 168 (2013), 2653–2657.
110. Wu, C.S., Nohr, E.A., Bech, B.H., Vestergaard, M., Olsen, J., Long-term health outcomes in children born to mothers with diabetes: a population-based cohort study. PLoS One, 7, 2012, e36727.
111. Vickers, M.H., Breier, B.H., Cutfield, W.S., et al. Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol Endocrinol Metab 279 (2000), E83–E87.
112. Vickers, M.H., Breier, B.H., McCarthy, D., Gluckman, P.D., Sedentary behavior during postnatal life is determined by the prenatal environment and exacerbated by postnatal hypercaloric nutrition. Am J Physiol Regul Integr Comp Physiol 285 (2003), R271–R273.
113. Corstius, H.B., Zimanyi, M.A., Maka, N., et al. Effect of intrauterine growth restriction on the number of cardiomyocytes in rat hearts. Pediatr Res 57 (2005), 796–800.
114. Lim, K., Zimanyi, M.A., Black, M.J., Effect of maternal protein restriction in rats on cardiac fibrosis and capillarization in adulthood. Pediatr Res 60 (2006), 83–87.
115. Menendez-Castro, C., Fahlbusch, F., Cordasic, N., et al. Early and late postnatal myocardial and vascular changes in a protein restriction rat model of intrauterine growth restriction. PLoS One, 6, 2011, e20369.
116. Elmes, M.J., Gardner, D.S., Langley-Evans, S.C., Fetal exposure to a maternal low-protein diet is associated with altered left ventricular pressure response to ischaemia-reperfusion injury. Br J Nutr 98 (2007), 93–100.
117. Cleal, J.K., Poore, K.R., Boullin, J.P., et al. Mismatched pre- and postnatal nutrition leads to cardiovascular dysfunction and altered renal function in adulthood. Proc Natl Acad Sci U S A 104 (2007), 9529–9533.
118. Langley-Evans, S.C., Welham, S.J.M., Jackson, A.A., Fetal exposure to a maternal low protein diet impairs nephrogenesis and promotes hypertension in the rat. Life Sci 64 (1999), 965–974.
119. Khorram, O., Momeni, M., Ferrini, M., Desai, M., Ross, M.G., In utero undernutrition in rats induces increased vascular smooth muscle content in the offspring. Am J Obstet Gynecol 196 (2007), 486.e1–486.e8.
120. Eixarch, E., Figueras, F., Hernández-Andrade, E., et al. An experimental model of fetal growth restriction based on selective ligature of uteroplacental vessels in the pregnant rabbit. Fetal Diagn Ther 26 (2009), 203–211.
121. Eixarch, E., Hernandez-Andrade, E., Crispi, F., et al. Impact on fetal mortality and cardiovascular Doppler of selective ligature of uteroplacental vessels compared with undernutrition in a rabbit model of intrauterine growth restriction. Placenta 32 (2011), 304–309.
122. Schipke, J., Gonzalez-Tendero, A., Cornejo, L., et al. Experimentally induced intrauterine growth restriction in rabbits leads to differential remodelling of left versus right ventricular myocardial microstructure. Histochem Cell Biol 148 (2017), 557–567.
123. Torre, I., González-Tendero, A., García-Cañadilla, P., et al. Permanent cardiac sarcomere changes in a rabbit model of intrauterine growth restriction. PLoS One, 9, 2014, e113067.
124. González-Tendero, A., Torre, I., Garcia-Canadilla, P., et al. Intrauterine growth restriction is associated with cardiac ultrastructural and gene expression changes related to the energetic metabolism in a rabbit model. Am J Physiol Heart Circ Physiol 305 (2013), H1752–H1760.
125. Iruretagoyena, J.I., Gonzalez-Tendero, A., Garcia-Canadilla, P., et al. Cardiac dysfunction is associated with altered sarcomere ultrastructure in intrauterine growth restriction. Am J Obstet Gynecol 210 (2014), 550.e1–550.e7.
126. Ream, M., Ray, A.M., Chandra, R., Chikaraishi, D.M., Early fetal hypoxia leads to growth restriction and myocardial thinning. Am J Physiol Regul Integr Comp Physiol 295 (2008), R583–R595.
127. Rueda-Clausen, C.F., Morton, J.S., Davidge, S.T., Effects of hypoxia-induced intrauterine growth restriction on cardiopulmonary structure and function during adulthood. Cardiovasc Res 81 (2009), 713–722.
128. Tong, W., Xue, Q., Li, Y., Zhang, L., Maternal hypoxia alters matrix metalloproteinase expression patterns and causes cardiac remodeling in fetal and neonatal rats. Am J Physiol Heart Circ Physiol 301 (2011), H2113–H2121.
129. Bae, S., Xiao, Y., Li, G., Casiano, C.A., Zhang, L., Effect of maternal chronic hypoxic exposure during gestation on apoptosis in fetal rat heart. Am J Physiol Heart Circ Physiol 285 (2003), H983–H990.
130. Tintu, A., Rouwet, E., Verlohren, S., et al. Hypoxia induces dilated cardiomyopathy in the chick embryo: mechanism, intervention, and long-term consequences. PLoS One, 4, 2009, e5155.
131. Sedmera, D., Pexieder, T., Rychterova, V., Hu, N., Clark, E.B., Remodeling of chick embryonic ventricular myoarchitecture under experimentally changed loading conditions. Anat Rec 254 (1999), 238–252.
132. Rueda-Clausen, C.F., Morton, J.S., Lopaschuk, G.D., Davidge, S.T., Long-term effects of intrauterine growth restriction on cardiac metabolism and susceptibility to ischaemia/reperfusion. Cardiovasc Res 90 (2011), 285–294.
133. Xu, Y., Williams, S.J., O'Brien, D., Davidge, S.T., Hypoxia or nutrient restriction during pregnancy in rats leads to progressive cardiac remodeling and impairs postischemic recovery in adult male offspring. FASEB J 20 (2006), 1251–1253.
134. Gluckman, P.D., Hanson, M.A., Buklijas, T., Low, F.M., Beedle, A.S., Epigenetic mechanisms that underpin metabolic and cardiovascular diseases. Nat Rev Endocrinol 5 (2009), 401–408.
135. Heijmans, B.T., Tobi, E.W., Stein, A.D., et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci 105 (2008), 17046–17049.
136. Einstein, F., Thompson, R.F., Bhagat, T.D., et al. Cytosine methylation dysregulation in neonates following intrauterine growth restriction. PLoS One, 5, 2010, e8887.
137. Williams, L., Seki, Y., Delahaye, F., et al. DNA hypermethylation of CD3(+) T cells from cord blood of infants exposed to intrauterine growth restriction. Diabetologia 59 (2016), 1714–1723.
138. Banister, C.E., Koestler, D.C., Maccani, M.A., et al. Infant growth restriction is associated with distinct patterns of DNA methylation in human placentas. Epigenetics 6 (2011), 920–927.
139. Ding, Y., Cui, H., Integrated analysis of genome-wide DNA methylation and gene expression data provide a regulatory network in intrauterine growth restriction. Life Sci 179 (2017), 60–65.
140. Aagaard-Tillery, K.M., Grove, K., Bishop, J., et al. Developmental origins of disease and determinants of chromatin structure: maternal diet modifies the primate fetal epigenome. J Mol Endocrinol 41 (2008), 91–102.
141. Sohi, G., Marchand, K., Revesz, A., Arany, E., Hardy, D.B., Maternal protein restriction elevates cholesterol in adult rat offspring due to repressive changes in histone modifications at the cholesterol 7alpha-hydroxylase promoter. Mol Endocrinol 25 (2011), 785–798.
142. Khorram, O., Han, G., Bagherpour, R., et al. Effect of maternal undernutrition on vascular expression of micro and messenger RNA in newborn and aging offspring. Am J Physiol Regul Integr Comp Physiol 298 (2010), R1366–R1374.
143. Gonzalez-Rodriguez, P., Cantu, J., O'Neil, D., et al. Alterations in expression of imprinted genes from the H19/IGF2 loci in a multigenerational model of intrauterine growth restriction (IUGR). Am J Obstet Gynecol 214 (2016), 625.e1–625.e11.
144. Ponzio, B.F., Carvalho, M.H.C., Fortes, Z.B., Franco, M.D.C., Implications of maternal nutrient restriction in transgenerational programming of hypertension and endothelial dysfunction across F1-F3 offspring. Life Sci 90 (2012), 571–577.
145. Haas, J., Frese, K.S., Park, Y.J., et al. Alterations in cardiac DNA methylation in human dilated cardiomyopathy. EMBO Mol Med 5 (2013), 413–429.
146. Movassagh, M., Choy, M.K., Knowles, D.A., et al. Distinct epigenomic features in end-stage failing human hearts. Circulation 124 (2011), 2411–2422.
147. Gilsbach, R., Preissl, S., Grüning, B.A., et al. Dynamic DNA methylation orchestrates cardiomyocyte development, maturation and disease. Nat Commun, 5, 2014, 5288.
148. Paradis, A., Xiao, D., Zhou, J., Zhang, L., Endothelin-1 promotes cardiomyocyte terminal differentiation in the developing heart via heightened DNA methylation. Int J Med Sci 11 (2014), 373–380.
149. Patterson, A.J., Xiao, D., Xiong, F., Dixon, B., Zhang, L., Hypoxia-derived oxidative stress mediates epigenetic repression of PKCε gene in foetal rat hearts. Cardiovasc Res 93 (2012), 302–310.
150. Alsaied, T., Omar, K., James, J.F., et al. Fetal origins of adult cardiac disease: a novel approach to prevent fetal growth restriction induced cardiac dysfunction using insulin like growth factor. Pediatr Res 51 (2017), 919–925.
151. Palou, M., Picó, C., McKay, J.A., et al. Protective effects of leptin during the suckling period against later obesity may be associated with changes in promoter methylation of the hypothalamic pro-opiomelanocortin gene. Br J Nutr 106 (2011), 769–778.
152. Vickers, M.H., Gluckman, P.D., Coveny, A.H., et al. Neonatal leptin treatment reverses developmental programming. Endocrinology 146 (2005), 4211–4216.
153. Burdge, G.C., Lillycrop, K.A., Phillips, E.S., et al. Folic acid supplementation during the juvenile-pubertal period in rats modifies the phenotype and epigenotype induced by prenatal nutrition. J Nutr 139 (2009), 1054–1060.
154. Rodriguez-Lopez, M., Osorio, L., Acosta, R., et al. Influence of breastfeeding and postnatal nutrition on cardiovascular remodeling induced by fetal growth restriction. Pediatr Res 79 (2016), 100–106.
155. Skilton, M.R., Ayer, J.G., Harmer, J.A., et al. Impaired fetal growth and arterial wall thickening: a randomized trial of omega-3 supplementation. Pediatrics 129 (2012), e698–e703.
156. Skilton, M.R., Raitakari, O.T., Celermajer, D.S., High intake of dietary long-chain ω-3 fatty acids is associated with lower blood pressure in children born with low birth weight: NHANES 2003-2008. Hypertension 61 (2013), 972–976.
157. Skilton, M.R., Ayer, J.G., Harmer, J.A., et al. Impaired fetal growth and arterial wall thickening: a randomized trial of ω-3 supplementation. Pediatrics, 129, 2012 e698-70.